Any program that prescribes GLP-1 without baseline labs (at minimum: fasting glucose, A1c, lipid panel, basic metabolic panel) is cutting corners that matter for safety
Interestingly, unc-51-like kinase 1 (ULK1) can phosphorylate FUNDC1 at the serine 17 site, Which promotes the interaction between FUNDC1 and its target to LC3, and when mitochondria are damaged, FUNDC1 recruits more ULK1 into mitochondria to induce mitophagy [63]
Shantavasinkul PC, Omotosho P, Corsino L, et al
Key Clinical Markers That May Influence Your GLP-1 Choice Beyond medication class, several biomarkers and clinical features may provide context for your provider's recommendation
Table of Contents If youre thinking about using BPC-157 to support recovery, reduce inflammation, or complement a regenerative treatment plan, you may have one practical concern: Will it show up on a drug test